After watching her live with dementia for 11 years, I'm relieved my mum's dead
Caring for my mother on top of caring for my child for the last six years made my life a shit sandwich. I'm not a natural nurturer, so taking on a carer's role with my mother was very difficult. She both created and was positioned in difficult situations that made everything all the harder. She ran away from the aged care centre she was living in and got together with a man who she claims ended up stealing money from her. She also had to endure COVID-19 lockdowns while in aged care .
I visited my mother every fortnight, which doesn't seem much. Though, after coping with her dementia for 11 years — and having the same conversations again and again about her boyfriend — my patience and love thinned. Dementia is hard on family members and "loving trips down memory lane" experiences are very rare. I found mum's aged care centre drab and dreary. It smelled horribly of chemicals, urine and death. When you get one day off a week, it's not the place you want to spend time. You force yourself to visit. To this day, I remember the stench.
My daughter refused to step foot in the door as the smell was too much. In my caring of my mother, I had to also balance and prioritise the needs of my child. As a parent, my job is to keep my vulnerable child safe. Unfortunately, my daughter suffered from consistent bullying for over a year at school. Dealing with my daughter's bullying situation, my mum dying, being a single mum and running a business while in my late 50s, was overwhelming. In the end, we can all only do the best we can do, but was I loving enough to my mother? Probably not. Some people talk about this glorious moment of seeing their loved one's last breath while holding their hand. But I wasn't with my mum when she died. I decided not to be. I had to make the choice of who needs me more. I hadn't really seen my daughter for three days and she needed me. I don't think anyone should die alone but I had said my goodbyes to my mother. Though, sometimes I do find myself hoping she didn't miss me not being there.
Dementia is the longest death, and in my mother's case, it was drawn out over 11 years. It was exhausting, depressing, lonely and extremely frustrating. I was her guardian for health, accommodation, medication. Every single part of her life, I was responsible. Because of that, I never felt like a daughter again. My role as her daughter ended years ago and I grieved it then.
Seeing my mother's health and mind deteriorate over a decade made me realise I will not be going into aged care. If I do end up getting dementia, for me, the decision to continue living or not, will be a very difficult one. I don't think I would choose to have that life. I would not want to be a burden for my daughter, who is going to struggle through life anyway.
But for now, the burden has been lifted and I'm in an era of freedom. I bought a campervan and have taken my daughter on road trips, and we've gone on overseas holidays to Bali and Thailand. We are reconnecting after I had to have split focus, taking care of my dying mother. It may sound horrible, but now that my mum is dead, I finally — at the age of 56 — get to have a life. Readers seeking confidential information and support on dementia can contact the National Dementia Helpline on 1800 100 500. Carer Gateway is an Australian government program providing free services and support for carers and can be contacted on 1800 422 737.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
an hour ago
- News.com.au
Hope grows as cannabis contender enters the Rett syndrome fight
Rett syndrome is rare but relentless Neuren struck biotech gold with Daybue Neurotech brings cannabis to the fight Rett syndrome is the kind of diagnosis that hits hard and lingers long. It affects around one in 10,000 girls, and typically appears after what seems like a normal start to life. Then comes the regression - loss of speech, hand skills, mobility - followed by the onset of seizures, bone fragility, gut issues, scoliosis and, often, a haunting silence that replaces early babble. It's caused by mutations in the MECP2 gene, which plays a crucial role in brain development. While it's classed as rare, the ripple effects through families are enormous. Sleep disturbances are common. Breathing irregularities, like breath-holding spells, can leave caregivers powerless. And while most girls survive into adulthood, it's with round-the-clock support and complex medical needs. AussieRett and InterRett studies Professor Helen Leonard, principal research fellow at the Kids Research Institute, has spent decades studying the condition. Leonard's long-running AussieRett and InterRett studies have helped establish how Rett symptoms evolve over time, and her team has also created global care guidelines for things like nutrition, scoliosis and bone health. 'Rett syndrome is an unusual condition in that it mainly affects girls who, following a period of apparent normal development, gradually show signs of regression," she told Stockhead. "Between the ages of 6 and 18 months they lose skills, particularly in relation to hand function and communication. 'As well as loss of hand function, these individuals develop unusual patterns of hand movements, such as hand-wringing or clapping known as stereotypies." Neuren's moonshot moment Until recently, there was no approved treatment for Rett, only a patchwork of management strategies and hope. That changed when ASX-listed Neuren Pharmaceuticals (ASX:NEU) struck gold with its drug trofinetide, now marketed as DAYBUE in the US. Approved by the FDA in March 2023, DAYBUE became the first and only drug for Rett syndrome, unlocking a commercial windfall for Neuren. Since 2019, Neuren's stock has surged over 1,200%, and the company now commands a $2 billion market cap. Thanks to a savvy licensing deal with Acadia Pharmaceuticals, Neuren pockets royalties and milestone payments with no royalty outgoings - every dollar drops to the bottom line. 'The FDA approval of trofinetide for Rett syndrome is very exciting, and represents the first ever treatment for the disorder,' said Leonard. For investors, it was a reminder that rare paediatric disorders, long overlooked, are now a serious biotech frontier. And that's where Neurotech (ASX:NTI) enters the frame, with a somewhat different approach. Cannabis steps into the ring Neurotech's lead therapy, NTI164, is a full-spectrum cannabis extract containing a cocktail of cannabinoids like CBDA, CBC and CBN. But it only contains 0.08% THC, meaning it's non-intoxicating and suitable for children. The company recently published results from its Phase I/II study in the Journal of Paediatrics and Child Health. This report shows the therapy was well tolerated and offered signs of clinical improvement across neurological, behavioural and functional domains. The drug's unique formulation is designed to reduce neuroinflammation, support synaptic function and modulate glial cells - factors believed to play a key role in Rett's progression. NTI164 is gaining traction internationally. It's already secured Orphan Drug Designation (ODD) in the US and European Union. This unlocks a range of incentives, including market exclusivity, reduced regulatory fees and access to research funding. It's the kind of support that can help fast-track rare-disease drugs through the system. Meanwhile, data from the same study was presented by lead investigator Professor Carolyn Ellaway at the World Rett Syndrome Congress. That put NTI164 front and centre in a growing global conversation about next-gen Rett treatments. Caution, hope and next steps Research into cannabis for Rett is still early, and Leonard urges caution when interpreting results from small, open-label trials. 'I think that we need a larger national double-blind placebo-controlled study before making any judgement,' she said. 'I would hope that this would use an alternative outcome measure to the RSBQ.' Her research has shown that Rett's behavioural symptoms - like those measured by the RSBQ - tend to decrease with age; unlike its clinical severity, which often worsens. That disconnect, she believes, can muddy trial results, and partially explains why she urges a broader toolkit for measuring impact in future studies. Still, she acknowledged that apart from the Rett Syndrome Symptom Severity (RTT-SIS) scale, some of the other measures used in the NTI164 study 'were showing positive changes'. She's not easily swayed by early signals but she recognises momentum when it's building. And regulators seem to agree. A closer look under NTI's hood From a clinical standpoint, NTI164 is ticking key boxes. Its pharmacokinetic (PK) data shows rapid absorption, minimal THC exposure and consistent dosing with no cannabinoid build-up - making it suitable for chronic paediatric use. NTI164 has also shown promising results in other paediatric neurological conditions like autism and PANDAS/PANS, potentially supporting its use in Rett by building a broader safety and efficacy profile. Perhaps most notably, its primary cannabinoid, CBDA, doesn't just convert into CBD like many assume. It appears to act directly on the brain, interacting with receptors linked to mood and inflammation. That matters because Rett isn't just neurological, it's deeply inflammatory. 'The clear validation of systemic stability, safety and targeted therapeutic action highlights NTI164's potential as a disease-modifying therapy,' said Neurotech CEO, Dr Anthony Filippis. Whether that turns into a commercial home run is still to be seen, but NTI164 has already demonstrated solid safety and early signs of symptom relief. In Rett, that bar is high. So are expectations. And that's what makes Neurotech's path an interesting one to watch. At Stockhead we tell it like it is. While Neurotech is a Stockhead advertiser, it did not sponsor this article.
ABC News
an hour ago
- ABC News
Bendigo psychiatrists suffer years of living in fear before patient remanded in custody
Mental health professionals say authorities failed to protect them from a violent patient who breached intervention orders numerous times. Warning: This article includes details of mental health episodes that may distress some readers. The two psychiatrists, whom the ABC will refer to as "Dr A" and "Dr J" to protect their identities, treated patient "Hannah" (not her real name) at Bendigo Health public hospital from 2014. Dr A had an intervention order in place against Hannah for more than seven years, but was allegedly attacked in her private practice in June. Dr A said Hannah forced her way into the consulting room while the practitioner was on a telehealth call with a patient. "She was yelling, '[I will] kill you,' while she was punching me," Dr A alleged. Hannah is now in custody after the alleged attack against her former psychiatrist. Dr A, Dr J and another mental health worker involved in her care, who the ABC will refer to as 'Tom', and was also assaulted by Hannah, believe this is the first time Hannah has been remanded in custody. Tom said Hannah's delusions led her to target doctors and nurses who had treated her because she falsely believed they were trying to harm her. "[It's] if she believes you've done her wrong, which she does with a lot of the doctors who have had to involuntarily treat her," Tom said. Court documents reveal Hannah was charged more than 40 times between 2014 and 2024 for offences including unlawful assault, stalking and trespassing. For most of that decade, she was in the care of Bendigo Health. Since 2018, Hannah has been convicted at least 14 times of breaching personal safety intervention orders, and placed on good behaviour bonds at least six times. The only time Hannah appears to have been remanded in custody was in June this year for the alleged assault of Dr A at their private practice. Victoria Police arrested Hannah three weeks after the alleged assault, and after the ABC made repeated inquiries. Dr A first asked Victoria Police for protection from Hannah in 2014. "She was making threats to kill me," Dr A wrote in an email to police. Dr A and Dr J also pleaded for intervention from their employer, Bendigo Health, Victoria's Office of the Chief Psychiatrist [OCP], the Minister for Mental Health and Minister for Health, and the local MP, Jacinta Allan, who is now the Victorian Premier. "This letter comes to you out of desperation and living in fear for the past six to seven years," Dr A wrote to the ministers in 2022. Both psychiatrists said their pleas to have Hannah admitted to a secure mental health facility were not acted on. "They are waiting for her to kill someone." "She's a ticking time bomb." Ms Allan's office responded to Dr A in January 2023, stating the matter had been urgently escalated. In a statement to the ABC, Ms Allan, who is the current MP for Bendigo East, declined to answer questions about the case but said violence towards any individual was "unacceptable". "Our hardworking healthcare workers in Bendigo deserve to feel safe and supported at work," the statement said. Another Bendigo psychiatrist, Dr J, was granted an intervention order against Hannah after being attacked by her in a car park near Bendigo Health in 2014. Since then, Dr J said she would only see patients via telehealth appointments. Dr J said Bendigo Health failed to always tell staff when they might be at risk. "The chief psychiatrist promised that we would always be kept in the loop about what was happening with her [Hannah], when she was admitted … when somebody had been beaten up," Dr J said. Bendigo Health's Mental Health Services clinical director, associate professor Philip Tune, wrote to staff in 2023, advising them that after nearly a decade of treating her, the hospital had decided to discharge Hannah. Dr Tune noted in the letter that the decision was made with the full support of the OCP. The Office of the Chief Psychiatrist declined to comment on the decision. A Victorian Health Department spokesperson said in a statement that "violence, harassment and bullying is never acceptable in the workplace." "The Office of the Chief Psychiatrist continues to support Bendigo Health to balance the wellbeing of consumers with any risk to staff and the community," the spokesperson said. Bendigo Health declined to respond to detailed questions about Hannah's treatment and its safety plan for staff, but said in a statement it took occupational violence "seriously". "Recent improvements include doubling our security investment across mental health facilities, expanding de-escalation training for mental health teams, and establishing occupational safety and violence committees," the spokesperson said. Experts say Hannah's case shows the under-resourcing of Victoria's secure mental health facilities. "It's impossible, really, for most people to get access to that level of care," former executive director of the state's secure mental health service, Forensicare, Professor James Ogloff said. "Unless someone is very unwell and commits a very serious offence, in which case they are arrested and processed and can be — for example — found not guilty by reason of mental impairment or incarcerated, do these service systems kick in," Professor Ogloff said. Professor Ogloff said Victoria's only secure mental health facility, the Thomas Embling Hospital in Melbourne, was meant to include patients inside the general mental health care system, as well as the criminal justice system. Acting chief executive of peak body Mental Health Victoria, Dan Brown, agreed that Hannah's case highlighted the "insufficient and inadequate" options for patients in Victoria's mental health system. "There is a need to free up expert crisis clinicians to respond to need in the community early," Mr Brown said. Hannah's lawyer told the Bendigo Magistrates Court on July 3, her client had difficulty trusting medical professionals following a 2011 hospital admission where she was restrained and forced to take medications. The court heard Hannah was living in her car and prone to obsessive behaviour, stalking and smashing windows. "She poses a large risk to the community," prosecutor Senior Constable Kate Christison told the court. The court heard Hannah had not engaged with mental health support since May 2024. Her lawyer told the court Hannah would sign a new NDIS service agreement if released, offering her about 18 hours of one-on-one support per week through a provider. The news of Hannah finally being in custody was welcomed by her former health professionals. "I am feeling so relieved," Dr A said. Hannah is due to reappear in court in October. "But … what will happen when she comes [out] in October?" Dr A said.
News.com.au
2 hours ago
- News.com.au
Fraser Cahill wanted to die with dignity - and he did that
EXCLUSIVE As 37-year-old Fraser Cahill sat rugged up, looking out to the ocean, surrounded by those he loved, he sipped on the liquid mixture his nurse prepared for him and then he gave her a wink. 'With that wink I knew what he was saying,' community palliative care nurse Beth Dineen recalls of that special day looking out over the ocean at Point Lonsdale, a scenic coastal hideaway in southern Victoria. 'He was saying 'we did it, we made this happen'. He was saying thank you.' The liquid would soon seep its way through Fraser's body, first putting him to sleep and then slowly and gently shutting down his vital organs. Fraser had already said his last goodbyes, listened to his favourite songs, hugged those he loved, and he was ready to take his last breath. The popular high-end real estate agent from Melbourne had battled a rare and aggressive form of duodenal cancer, keeping his diagnosis a secret for as long as he could while undergoing chemotherapy. He thought he had won the battle but the cancer returned after Christmas last year – this time it was more ferocious and doctors agreed Fraser had just weeks to live. 'When Frase said he wanted to come down to Point Lonsdale for his final days, the hospital put a referral into Bellarine Community Health Palliative Care. That's where I came in,' Beth told 'When I first met Fraser at his home I had the doctor with me, and you could just tell he was someone who did things his own way,' she recalls. 'He was just very full of life despite his situation, his circumstances. And one of the first things he had said was that he wanted to do Voluntary Assisted Dying (VAD) down at the beach. 'And I remember getting back in the car saying to the doctor, 'It's fine. We've got a bit of time to talk him out of it', because conventionally, logistically that doesn't normally happen. 'As I got to know Fraser and his family more, it became a case of 'We've got to make this happen no matter what it takes. They're going to do it anyway. So let's just, let's help them do it, and let's sort of break some of those barriers with VAD'.' Fraser, with the help of nurse Beth and his brother Wes, began scoping out locations and soon settled on the perfect spot. Not everyone was on board with his decision – the Catholic respite care facility taking care of him would not allow conversations about VAD to take place within their four walls. Fraser's mum Mandy recalls the family having to sneak Fraser out for appointments with VAD facilitators. 'The doctors and the staff weren't allowed to talk about it. We found that quite incredible. This was Fraser's choice after all.' Go Gentle Australia's CEO Dr Linda Swan told that VAD 'eases suffering and gives dying people comfort in their final days'. 'It's therefore disappointing that a faith-based facility made Fraser's choice harder than it needed to be. While a facility can elect not to participate in VAD, they should not stand in the way of someone's legal choice. Their objection should never become obstruction and it should never cause harm.' Wes says the attitude in the care facility was just one of the many challenges along the way but he was 'stopping at nothing' to make Fraser's wish come true. Once the location was chosen – a lookout at Point Lonsdale's back beach – Beth and Wes set about alerting authorities that there would be an 'unusual gathering'. 'We had to think about how we could get Fraser's body down the steep hill afterwards so we looked into where we could get a stretcher,' Wes said. Beth spoke to the local police. 'I explained that this really is no different to someone going to the beach and taking a substance and waiting for someone to find them because that's the reality of what happens,' she said. 'So we explained that this way, we were going to control the situation as best we could. 'We also decided to use a family vehicle that we could safely put him in so yes, there was a lot to manage and navigate.' Fraser decided on a Tuesday in March that he would die the following Friday, knowing his health was declining rapidly. After a family dinner on Thursday night, when Friday came, he had no second thoughts, no tears. Not once did he question 'why me?' instead telling his mum it was just bad luck and he'd had a good run. He walked up the hill, side-by-side with his siblings, to his chosen spot, just like he had planned. 'He had cuddles and last chats with everyone. He sat in his chair and shared those last special moments with the ones he loved, and then when he was ready he drank his drink,' Wes said. 'I think because he was such a positive person and so uplifting, he didn't ever really want to talk about being scared or anything. 'He was just so positive and brave. Maybe internally, he was worried about getting sicker and not having control of his body, so he wanted a nice passing, he wanted to make the most of his last few months and die with dignity and he did that.' Both Beth and Wes are passionate about breaking down barriers and stamping out stigma associated with VAD – which is legal in all six Australian states and the ACT. Northern Territory is expected to soon follow suit. According to Go Gentle Australia, residents strongly back voluntary assisted dying laws, with support in most recent polls running between 70 and 90 per cent. Each state though has different requirements and supporters argue accessing the process should be more streamlined. Beth said it was an honour to help Fraser leave the world the way he had planned. She urges people with terminal illnesses – in situations like Fraser – to ask questions, find out what the rules are in their own state. 'Fraser used to talk about not contributing to the circle of life anymore, and I think he would be very proud to see how much he's actually still contributing despite him not being here anymore. He should be very proud.'
